Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pembrolizumab (keytruda) (1 trial)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Trials (1 total)
Trial APIs (1 total)